Israel Englander’s Xtant Medical Holdings XTNT Stock Holding History

Israel Englander’s Portfolio XTNT Stock Details XTNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.6K	Sell	84,490 -47,864	-36%	-$23K	﹤0.01%	5648
2026 Q1	$73.9K	Sell	132,354 -58,492	-31%	-$36K	﹤0.01%	5385
2025 Q4	$150K	Sell	190,846 -52,078	-21%	-$37.8K	﹤0.01%	5545
2025 Q3	$158K	Sell	242,924 -19,575	-7%	-$12.3K	﹤0.01%	5608
2025 Q2	$194K	Buy	+262,499	New	+$149K	﹤0.01%	5375
2025 Q1	–	Sell	-19,379	Closed	-$8.59K	–	6481
2024 Q4	$8.59K	Sell	19,379 -25,984	-57%	-$12.6K	﹤0.01%	5793
2024 Q3	$30.7K	Sell	45,363 -17,319	-28%	-$11.5K	﹤0.01%	5750
2024 Q2	$39.5K	Sell	62,682 -175,923	-74%	-$140K	﹤0.01%	5451
2024 Q1	$279K	Buy	238,605 +79,255	+50%	+$86.9K	﹤0.01%	5175
2023 Q4	$180K	Buy	+159,350	New	+$187K	﹤0.01%	5211
2023 Q1	–	Sell	-25,795	Closed	-$17K	–	6939
2022 Q4	$17K	Buy	+25,795	New	+$16.9K	﹤0.01%	6087
2021 Q2	–	Sell	-11,786	Closed	-$28K	–	7196
2021 Q1	$28K	Sell	11,786 -6,720	-36%	-$14.4K	﹤0.01%	5808
2020 Q4	$22K	Buy	+18,506	New	+$23.8K	﹤0.01%	5130
2016 Q2	–	Sell	-1,851	Closed	-$60K	–	3655
2016 Q1	$60K	Buy	+1,851	New	+$59.1K	﹤0.01%	3141

Other funds holding XTNT

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Israel Englander's XTNT Position: Q2 2026 in Review

Israel Englander reduced its Xtant Medical Holdings (XTNT) stake by 36% in Q2 2026, selling an estimated $23K and leaving 84,490 shares worth $35.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5648.

Israel Englander first reported a position in XTNT in Q1 2016 and has held it in 14 quarters since. The position peaked at $279K in Q1 2024. 32 funds tracked by Wall St. Rank hold XTNT as of Q2 2026.

Israel Englander held 84,490 shares of Xtant Medical Holdings worth $35.6K as of Q2 2026.
Israel Englander sold 47,864 Xtant Medical Holdings shares in Q2 2026, an estimated $23K.
Xtant Medical Holdings made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #5648 holding.
Israel Englander first reported a position in Xtant Medical Holdings in Q1 2016 and has held it in 14 quarters since.
Israel Englander's Xtant Medical Holdings position peaked at $279K in Q1 2024.
32 funds tracked by Wall St. Rank held Xtant Medical Holdings as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.